ArticleDrug design, development and therapy2026
Outcomes and Safety of PD-1 Blockades Plus Anlotinib Regimen in Previously-Treated Metastatic Esophageal Squamous Cell Carcinoma: A Retrospective, Exploratory Study.
Song Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.